Newron Pharmaceuticals SpA (NWRN) — Free Cash Flow Generation Index
Newron Pharmaceuticals SpA (NWRN) has a Free Cash Flow Generation Index of 1.00x as of June 2025. Free cash flow of CHF33.32 Million represents 1% of operating cash flow (CHF33.35 Million). Explore capital reinvestment ratio of Newron Pharmaceuticals SpA to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Newron Pharmaceuticals SpA Free Cash Flow Generation Index (2012–2025)
Historical FCF Generation Index trend for Newron Pharmaceuticals SpA across 2 annual periods. For the full cash flow conversion analysis, see Newron Pharmaceuticals SpA cash flow conversion.
Annual Free Cash Flow Generation for Newron Pharmaceuticals SpA (2012–2025)
Year-by-year Free Cash Flow Generation Index for Newron Pharmaceuticals SpA. Check NWRN cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CHF) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | CHF32.51 Million | CHF32.56 Million | CHF47.30K | ▲ +0.0% |
| 2012 | 1.00x | CHF5.81 Million | CHF5.83 Million | CHF11.00K | — |